Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Operating Leases (2022 - 2025)

Core Scientific has reported Operating Leases over the past 4 years, most recently at $95.0 million for Q1 2025.

  • Quarterly results put Operating Leases at $95.0 million for Q1 2025, up 37.57% from a year ago — trailing twelve months through Mar 2025 was $95.0 million (up 37.57% YoY), and the annual figure for FY2024 was $97.8 million, up 6371.1%.
  • Operating Leases reached $95.0 million in Q1 2025 per CORZ's latest filing, down from $97.8 million in the prior quarter.
  • Across five years, Operating Leases topped out at $97.8 million in Q4 2024 and bottomed at $720000.0 in Q4 2022.
  • Median Operating Leases over the past 4 years was $33.4 million (2023), compared with a mean of $40.5 million.
  • The largest annual shift saw Operating Leases soared 6442.37% in 2024 before it skyrocketed 37.57% in 2025.
  • Over 4 years, Operating Leases stood at $720000.0 in 2022, then skyrocketed by 110.0% to $1.5 million in 2023, then soared by 6371.1% to $97.8 million in 2024, then dropped by 2.95% to $95.0 million in 2025.
  • Business Quant data shows Operating Leases for CORZ at $95.0 million in Q1 2025, $97.8 million in Q4 2024, and $65.3 million in Q3 2024.